when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

NOVO · news · pharmadog

← back to NOVO

News mentioning NOVO

476 stories

Sep 14, 26Abbott agrees to settlement over closure of largest baby formula plant in the U.S.stat

Sep 14, 26Pennsylvania officials report state’s third death involving measlesstat

Sep 14, 26STAT+: GSK touts lung cancer data from two drugsstat

Sep 14, 26Novo drops ‘Nordisk’ moniker, turns bull toward future in corporate rebrandbiospace

Sep 14, 26STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and morestat

Sep 14, 26Scholar Rock secures first FDA approval for muscle-targeting rare disease drugbiospace

Sep 14, 26Novo Nordisk shortens its name in brand and culture rebootendpoints

Sep 14, 26STAT+: Definium’s LSD therapy eased anxiety in second large trialstat

Sep 14, 26Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofifiercebiotech

Sep 14, 26STAT+: What’s in a name? Novo looks to a rebrandstat

Sep 14, 26Cyclic peptides open new drug frontiers, if manufacturing can keep upbiospace

Sep 14, 26No more Nordisk as Novo goes it alone amid rebranding pushfiercebiotech

Sep 11, 26STAT+: Scholar Rock wins FDA approval for first drug to target SMA muscle lossstat

Sep 11, 26STAT+: Cancer drug shortages keep disrupting patient carestat

Sep 11, 26Boycott launched against American Diabetes Association includes journalstat

Sep 11, 26Takeda's R&D chief Andy Plump to retire; Novo Nordisk appoints global research headendpoints

Sep 11, 26STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the fieldstat

Sep 11, 26STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGsstat

Sep 10, 26Why two promising heart drugs flopped and what’s nextstat

Sep 10, 26STAT+: The gifts from pharma companies that keep on givingstat

Sep 10, 26STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and morestat

Sep 10, 26STAT+: Cancer medicines remain in short supply across the U.S., survey findsstat

Sep 10, 26A booming business on Wall Street would love more biotechs to quietly diebiopharma dive

Sep 9, 26Webinar: The Massive Scale of GLP-1s: Evolving Health, Healthcare and Marketsbiospace

Sep 9, 26STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and morestat

Sep 9, 26Novo’s canned heart disease trials, Novartis’ clinical fails, first approval for Alexander diseasebiospace

Sep 8, 26STAT+: FDA names acting heads of drug and vaccine centers to permanent rolesstat

Sep 8, 26STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandalsstat

Sep 8, 26Krazati withdrawal completed; Wegovy trial meets endpoint for kids ages 6 to 12endpoints

Sep 8, 26Structure’s obesity portfolio impresses on GLP-1 and amylin fronts in dual data dropbiospace

← prevpage 7 of 16next →